Has Edward Dabrowski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $392,339 in general payments to Edward Dabrowski, MD across 836 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Dabrowski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Dabrowski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Dabrowski, MD

Physical Medicine & Rehabilitation · Roseville, MINPI 1548230253

Payments from drug & device makers

$392,339in general payments, 2019–2025

Across 836 payments — averaging $469.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ipsen Biopharmaceuticals, Inc$178K
Ipsen Pharma SAS$115K
AbbVie$45K
Acadia Pharmaceuticals Inc$15K
MDD US Operations, LLC$10K
Neurocrine Biosciences, Inc.$8K
plus $20K from 51 others

$15,750in research payments, 2019–2025

Across 1 payment — averaging $15,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merz Pharmaceuticals, LLC$16K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ipsen Biopharmaceuticals, Inc	190	$178,378
Ipsen Pharma SAS	103	$115,420
AbbVie(2 entities)	131	$45,003
Acadia Pharmaceuticals Inc	24	$15,160
MDD US Operations, LLC	66	$10,092
Neurocrine Biosciences, Inc.	8	$8,165
Ipsen Innovation	6	$7,644
PTC Therapeutics, Inc.	10	$3,238
Merz North America, Inc.	8	$2,464
Merz Pharmaceuticals, LLC	30	$1,434
Biogen	22	$576
Neurelis, Inc.	25	$536
Novartis	31	$380
Electromed, Inc.	24	$368
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	3	$316
Supernus Pharmaceuticals, Inc.	18	$237
Bayer	2	$236
AstraZeneca	11	$234
Ironshore Pharmaceuticals Inc.	8	$152
Amgen	7	$147
Boston Scientific	2	$139
Philips North America LLC	7	$127
Takeda Pharmaceuticals U.S.A., Inc.	4	$113
Jazz Pharmaceuticals Inc.	5	$110
UCB, Inc.	6	$108
Lilly USA, LLC	7	$105
Alnylam Pharmaceuticals Inc.	5	$103
Teva Pharmaceuticals USA, Inc.	7	$101
Saol Therapeutics Inc.	5	$100
Sanofi	5	$96
Piramal Critical Care	1	$81
Biohaven Pharmaceutical Holding Company Ltd.	5	$78
Eisai Inc.	4	$72
Aprecia Pharmaceuticals, LLC	4	$68
SK Life Science, Inc.	3	$65
Zyla Life Sciences, Inc.	5	$64
CSL Behring	3	$59
Revance Therapeutics, Inc.	2	$57
Corium, LLC	5	$57
TG Therapeutics, Inc.	2	$49
Sunovion Pharmaceuticals Inc.	3	$43
Johnson & Johnson	1	$36
Medtronic(2 entities)	2	$34
Pfizer	2	$31
Ultragenyx Pharmaceutical Inc.	1	$26
Acorda Therapeutics, Inc	1	$25
Genentech USA, Inc.	2	$23
Amneal Pharmaceuticals LLC	1	$23
Adamas Pharmaceuticals, Inc.	1	$22
Otsuka America Pharmaceutical, Inc.	1	$21
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$21
Collegium Pharmaceutical, Inc.	1	$20
Akcea Therapeutics, Inc.	1	$20
Azurity Pharmaceuticals, Inc.	1	$18
Greenwich Biosciences, Inc.	1	$17
Avanir Pharmaceuticals, Inc.	1	$12
Biohaven Pharmaceuticals, Inc.	1	$12

How this compares

$392,339 in reported general payments places this provider in the 95th percentile of 469 physical medicine & rehabilitation providers in Michigan.

See all physical medicine & rehabilitation providers in Michigan →

Medicare billing

Part B allowed, 2024

$359,647

Medicare patients

137

Services billed

45,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Roseville

Gianna Maria RodriguezAnn Arbor$136K
Alecia DaunterAnn Arbor$83K
Johnathan HoDearborn$65K
Erika ErlandsonAnn Arbor$54K
David WeingardenClinton Township$34K
Jonathan VandenbergGrand Rapids$34K
Mathew SaffarianEast Lansing$24K
Randolph RussoGrand Rapids$22K
Jason PeterTroy$20K
Robert KrasnickAnn Arbor$20K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →